WELLINGTON MANAGEMENT GROUP LLP

Position in FATE — Fate Therapeutics Inc

CIK 902219 Boston, MA

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$663,697

+$417,171 QoQ

Shares Held

245,814

+227.0% QoQ

Ownership

0.205%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 156 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 70% None 30%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. FATE ranks #179 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$663,697	245,814	+227.0%	Shares	Defined	2026-08-14
2024-06-30	$246,526	75,161	+70.1%	Shares	Defined	2024-08-14
2024-03-31	$324,315	44,185	-92.2%	Shares	Defined	2024-05-15
2022-09-30	$12,737,440	568,382	-3.8%	Shares	Defined	2022-11-14
2022-06-30	$14,637,024	590,679	-19.2%	Shares	Defined	2022-08-15
2022-03-31	$28,345,715	731,125	+4.5%	Shares	Defined	2022-05-16
2021-12-31	$40,942,487	699,752	+14.6%	Shares	Defined	2022-02-11
2021-09-30	$36,186,704	610,540	+143.2%	Shares	Defined	2021-11-15
2021-06-30	$21,784,722	251,005	+39.1%	Shares	Defined	2021-08-16
2021-03-31	$14,877,937	180,448	-7.1%	Shares	Defined	2021-05-17
2020-12-31	$17,662,697	194,245	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.